Drug Profile
A 854777
Latest Information Update: 18 Oct 1994
Price :
$50
*
At a glance
- Originator Aventis
- Class Anti-inflammatories; Antirheumatics
- Mechanism of Action Immunomodulators
-
Orphan Drug Status
Orphan designation is assigned by a regulatory body to encourage companies to develop drugs for rare diseases.
Highest Development Phases
- Discontinued Rheumatic disorders